Skip to content
OpenCapital
Get started

Tango Therapeutics TNGX Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$912M+0.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
——
Guardant Health logo
Guardant HealthGH
——
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
——
Moderna logo
ModernaMRNA
——

Other financials

Income statement

See full
Revenue--100%
Operating income-$48.8M-14.7%
Net income-$45.5M-14.1%
EPS (diluted)-$0.32+11.1%

Balance sheet

See full
Cash & equivalents$160.0M+162%
Total debt$32.8M-11.3%
Total equity$391.5M+135%
Total assets$435.8M+58.9%

Cash flow

See full
Operating cash flow-$44.4M-6.4%
CapEx-$2.0K-104%
Free cash flow-$44.4M-6.3%

Valuation

See full
Market cap$4.55B+1,915%
Enterprise value$4.43B+2,204%
P/S79.9×+74.4×

Profitability

See full
Operating margin-206.2%-61.0pp
Net margin-188.2%-55.4pp
FCF margin-250.1%-49.4pp

Returns & leverage

See full
Return on equity-38.4%-10.5pp
Debt / equity0.1×-0.1×
Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tango Therapeutics's available for sale securities debt securities current?
Tango Therapeutics (TNGX) reported available for sale securities debt securities current of $222.01M in Q1 2026.
How has Tango Therapeutics's available for sale securities debt securities current changed year-over-year?
Tango Therapeutics's available for sale securities debt securities current increased by 40.3% year-over-year, from $158.29M to $222.01M.
What is the long-term trend for Tango Therapeutics's available for sale securities debt securities current?
Over 5 years (2020 to 2025), Tango Therapeutics's available for sale securities debt securities current has grown at a 7.3% compound annual growth rate (CAGR), from $161.94M to $230.86M.